Standing Order
Gilead Sciences, Inc.

Dashboard

Gilead Sciences, Inc.

GILDNASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$188B
Price$151.3752w $105.93 – $155.80
Conviction3/ 5
Revenue (TTM)$30.5B
Revenue growth YoY+5.5%
P/E (trailing)
Gross margin79.6%
Operating margin-4.6%
Net margin-10.6%
52w price change+39.0%
Next earningsOct 29, 2026

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Sep 23
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Sep 16
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Sep 16
    Ownership changeSEC

    Form 4 insider beneficial ownership change filing.

  • Sep 11
    Ownership changeSEC

    Form 4 filing reporting change in beneficial ownership by insider at Gilead Sciences.

  • Sep 11
    Ownership changeSEC

    SEC Form 4 filing reporting insider beneficial ownership change.

  • Sep 11
    Ownership changeSEC

    SEC Form 4 insider transaction filing

  • Sep 11
    Ownership changeSEC

    Form 4 insider transaction filing by Gilead officer or director.

  • Sep 11
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Sep 2
    Ownership changeSEC

    Form 4 filing reporting change in beneficial ownership by insider.

  • Aug 27
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Aug 21
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Aug 18
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Aug 18
    Ownership changeSEC

    SEC Form 4 insider transaction report filed

  • Aug 11
    Ownership changeSEC

    SEC Form 4 insider ownership change filing.

  • Aug 6
    Securities offeringSEC

    Filed S-3ASR automatic shelf registration statement.

  • Aug 4
    Ownership changeSEC

    SEC Form 4 insider transaction filing

  • Aug 4
    Financial resultsSEC

    Gilead Sciences filed 8-K (items 2.02, 9.01) reporting financial results and exhibits.

  • Jul 16
    Ownership changeSEC

    Form 4 insider transaction filing by Gilead executive.

  • Jul 16
    Ownership changeSEC

    Form 4 insider transaction filing reported for GILD.

  • Jul 2
    Ownership changeSEC

    Form 4 insider ownership change filing for GILD.

Not financial advice — research and opinion only. Disclosures